Leuprolide Acetate Market size was valued at USD 2.3 billion in 2024 and is likely to cross USD 5.41 billion by 2037, registering more than 6.8% CAGR during the forecast period i.e., between 2025-2037. In the year 2025, the industry size of chip-on-board LED is estimated at USD 2.43 billion. The reason behind the growth is impelled by the growing cases of cancer across the globe. Cancer is currently the third biggest cause of mortality which is majorly caused owing to the combined effects of genetic differences, environmental variables, and dietary decisions.
Advanced cancer patients may use leuprolide acetate as a palliative treatment since it is a well-known luteinizing hormone-releasing hormone (LHRH) agonist in prostate cancer. To grow and spread, the majority of prostate cancer forms require the hormone testosterone. According to estimates, in 2040, there will be more than 28 million new instances of cancer worldwide.
The growing prevalence of uterus fibroids are believed to fuel the leuprolide acetate market . For instance, in women of reproductive age, fibroids are the most prevalent type of pelvic tumor, and by the time they are 50 years old, more than 50% of women have fibroids.
Leuprolide acetate is the most popular drug for treating uterine fibroids in women since it has been approved for reducing the size of fibroids.
Growth Drivers
Challenges
|
Base Year |
2024 |
|
Forecast Year |
2025-2037 |
|
CAGR |
6.8% |
|
Base Year Market Size (2024) |
USD 2.3 billion |
|
Forecast Year Market Size (2037) |
USD 5.41 billion |
|
Regional Scope |
|
Product (Vials, Prefilled Syringes, Lyophilized Powder)
The prefilled syringes segment in the leuprolide acetate market is estimated to gain a robust revenue share of 48% in the coming years owing to the benefits offered by prefilled syringes. Prefilled syringes provide a high degree of accuracy since they are convenient to use and maintain the drug's potency, strength, and purity throughout its shelf life. These syringes make the procedure of giving a medication product to a patient safer, faster, and simpler and can reduce the cost. Moreover, LUPRON DEPOT is offered as prefilled dual-chamber syringes, which are, disposable syringes filled with a prescribed unit amount of medication.
Distribution Channel (Retail Pharmacy, Hospital Pharmacy, Online Pharmacy)
Leuprolide acetate market from the online pharmacy segment is set to garner a notable share shortly on the account of growing demand for online shopping. The preference of people is shifting toward online shopping to purchase medicinal drugs through online pharmacies since it saves time and effort. Moreover, an online pharmacy guarantees quick medication search, selection, and ordering, and also gives customers anonymity, which has made it a popular method of purchase for many customers. This could lead to an increase in demand for medications including leuprolide acetate through online channels.
Our in-depth analysis of the global leuprolide acetate market includes the following segments:
|
Product |
|
|
Route of Administration |
|
|
Application |
|
|
Distribution Channel |
|
North American Market Forecast
North America industry is likely to hold largest revenue share of 40% by 2037, impelled by the growing spending in healthcare. This would improve medical access which will drive more patients to seek the diagnosis of several diseases such as prostate cancer, and fertility issues in the region, leading to higher demand for leuprolide acetate. In 2021, health spending in the US increased by over 2%.
European Market Statistics
The Europe leuprolide acetate market is estimated to be the second largest, during the forecast timeframe led by advancements in medical care. As a result more effective leuprolide acetate is being developed in the region which increased its adoption to manage conditions such as fertility issues, and prostate cancer.
Author Credits: Radhika Pawar
Copyright © 2024 Research Nester. All Rights Reserved
FREE Sample Copy includes market overview, growth trends, statistical charts & tables, forecast estimates, and much more.
Have questions before ordering this report?